Regulations.gov document
Exhibit 1 Parts 1-2 re: Patent Extension Application from Bristol-Myers Squibb Company
Supporting & Related Material · FDA-2023-E-2460 · posted Jun 15, 2023
Key facts
| Document ID | FDA-2023-E-2460-0003 |
|---|---|
| Title | Exhibit 1 Parts 1-2 re: Patent Extension Application from Bristol-Myers Squibb Company |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2023-E-2460 |
| Posted | Jun 15, 2023 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: